Bay Area Tumor Institute CCOP

湾区肿瘤研究所 CCOP

• 批准号: 8305245
• 负责人: James Feusner
• 金额: $ 48.62万
• 依托单位: BAY AREA TUMOR INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-06-25 至 2015-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8305245
• 关键词: Adoption; Adult; African American; Area; Asians; Awareness; California; Cancer Control; Cancer Control Research; Cancer Patient; Cancer and Leukemia Group B; Childhood; Clinical; Clinical Research; Clinical Trials; Commit; Communities; Community Clinical Oncology Program; Community Hospitals; County; County Hospitals; Diagnosis; Education; Female; Financial Support; Fostering; Gender; General Population; Geography; Goals; Hispanics; Hospitals; Institutes; Lead; Low income; Malignant Neoplasms; Medical; Methods; Minority; National Surgical Adjuvant Breast and Bowel Project; Outcomes Research; Participant; Patients; Pediatric Oncology; Pharmaceutical Preparations; Physicians; Population; Populations at Risk; Prevention Research; Procedures; Protocols documentation; Public Health; Race; Radiation Therapy Oncology Group; Research; Research Personnel; Resources; San Francisco; Sex Orientation; Southwest Oncology Group; Therapeutic; Therapeutic Human Experimentation; Therapeutic Studies; Therapy Clinical Trials; base; cancer epidemiology; cancer prevention; control trial; data management; disability; experience; improved; outreach; prevent; programs; standard of care; tumor

DESCRIPTION (provided by applicant): The Bay Area Tumor Institute Community Clinical Oncology Program (BATI-CCOP) is a consortium of 6 community and county hospitals in Greater Oakland, California. It was founded in 1979 as a CGOP and converted to CCOP status in 1989. With a special emphasis on the recruitment of minority, low Income, pediatric, non-English-speaking, and female populations in three Bay Area Counties, the BATI-CCOP enables cancer patients and the general "at risk" population to participate in the clinical, cancer control and prevention research of CALGB, SWOG, NSABP, RTOG, CTSU, COG, and HLMCC. The long-term objectives and specific aims of the BATI-CCOP include accrual to therapeutic trials at higher rates than comparable CCOPs, accrual of minority and pediatric patients at higher rates than all other CCOPs, aggressive cancer control recruitment that exceeds NCI's cancer control research requirements, and increased interaction with research bases. The CCOP will continue to accrue 95% of all eligible pediatric oncology patients in the region and will continue to excel n the recruitment of minority and female participants, essentially enabling the BATI-CCOP to fulfill the requirements of all three types of CCOP's (an adult CCOP, a Minority-Based CCOP, and a Pediatric CCOP). The CCOP will also continue to exceed NCI mandates and remain the Bay Area leader in accrual to cancer prevention and control trials. The BATI-CCOP offers a successful long-term track record, an organized and committed medical community, experienced physician investigators, institutional and financial support from the Bay Area Tumor Institute, and unusual access to African American, Hispanic, Asian, pediatric, underserved, and female populations. PUBLIC HEALTH RELEVANCE: This research seeks to improve public health by enabling physicians and cancer patients to participate in clinical trials research. The research outcomes are expected to lead to the identification and dissemination of improved methods to diagnose, treat, or prevent cancer.

描述（由申请人提供）：湾区肿瘤研究所社区临床肿瘤学项目（BATI-CCOP）是由加州大奥克兰的6家社区和县级医院组成的联盟。它成立于1979年，作为一个CGOP，并于1989年转换为CCOP地位。特别强调在三个湾区县招募少数民族，低收入，儿科，非英语和女性人口，BATI-CCOP使癌症患者和一般“高危”人群能够参与CALGB，SWOG，NSABP，RTOG，CTSU，COG和HLMCC的临床，癌症控制和预防研究。BATI-CCOP的长期目标和具体目标包括以比可比CCOP更高的速率进行治疗试验，以比所有其他CCOP更高的速率进行少数民族和儿科患者的累积，超过NCI癌症控制研究要求的积极癌症控制招募，以及增加与研究基地的互动。CCOP将继续招募该地区95%的合格儿科肿瘤患者，并将继续在招募少数民族和女性参与者方面表现出色，基本上使BATI-CCOP能够满足所有三种类型CCOP的要求（成人CCOP、基于少数民族的CCOP和儿科CCOP）。CCOP还将继续超越NCI的授权，并继续成为湾区癌症预防和控制试验的领导者。BATI-CCOP提供了一个成功的长期跟踪记录，一个有组织和承诺的医疗社区，经验丰富的医生研究人员，来自湾区肿瘤研究所的机构和财政支持，以及对非裔美国人，西班牙裔，亚洲人，儿科，服务不足和女性人群的不寻常的访问。 公共卫生相关性：这项研究旨在通过使医生和癌症患者参与临床试验研究来改善公共健康。研究结果有望导致诊断，治疗或预防癌症的改进方法的识别和传播。